Named on one round in the feed.
Since 2026-10-01
ROUNDS
1
as lead investor
LED ROUNDS · USD
$31.3M
across 1 round · 1 co-led, split evenly
CO-INVESTORS
2
named beside it
Named on one round in the feed.
Since 2026-10-01
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
TriGemX Bio A biotechnology company focused on developing a medicines for the treatment of migraine | Funding round Verified against 3 of 4 sources | $94M | 2026-10-01 | [ LEAD ] |